Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Endocarditis history and symptoms

Introduction

Overview

Overview

Common symptoms of endocarditis include fever, chills, anorexia, malaise, weight loss, and back pain.

History and Symptoms

History and Symptoms

History

Patients with endocarditis may have a positive history of:[1][2][3][4][5][6][7]

Common Symptoms

Subacute bacterial endocarditis has an insidious onset while acute bacterial endocarditis is abrupt in onset.

Bacterial Endocarditis

Common symptoms of endocarditis include:[8][9][10][11]

Endocarditis Associated with Parenteral Drug Use

Common symptoms of endocarditis in intravenous drug abusers are:

Prosthetic Valve Endocarditis
References

References

  1. ↑ Arvay A, Lengyel M (1988). “Incidence and risk factors of prosthetic valve endocarditis”. Eur J Cardiothorac Surg. 2 (5): 340–6. PMID 3272238.
  2. ↑ Mylonakis E, Calderwood SB (2001). “Infective endocarditis in adults”. N Engl J Med. 345 (18): 1318–30. doi:10.1056/NEJMra010082. PMID 11794152.
  3. ↑ Corrigall, Denton; Bolen, James; Hancock, E.William; Popp, Richard L. (1977). “Mitral valve prolapse and infective endocarditis”. The American Journal of Medicine. 63 (2): 215–222. doi:10.1016/0002-9343(77)90235-2. ISSN 0002-9343.
  4. ↑ Sousa, C.; Botelho, C.; Rodrigues, D.; Azeredo, J.; Oliveira, R. (2012). “Infective endocarditis in intravenous drug abusers: an update”. European Journal of Clinical Microbiology & Infectious Diseases. 31 (11): 2905–2910. doi:10.1007/s10096-012-1675-x. ISSN 0934-9723.
  5. ↑ Sohail, Muhammad R.; Uslan, Daniel Z.; Khan, Akbar H.; Friedman, Paul A.; Hayes, David L.; Wilson, Walter R.; Steckelberg, James M.; Jenkins, Sarah M.; Baddour, Larry M. (2008). “Infective Endocarditis Complicating Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infection”. Mayo Clinic Proceedings. 83 (1): 46–53. doi:10.4065/83.1.46. ISSN 0025-6196.
  6. ↑ Moyssakis, Ioannis; Tektonidou, Maria G.; Vasilliou, Vassilios A.; Samarkos, Michael; Votteas, Vassilios; Moutsopoulos, Haralampos M. (2007). “Libman-Sacks Endocarditis in Systemic Lupus Erythematosus: Prevalence, Associations, and Evolution”. The American Journal of Medicine. 120 (7): 636–642. doi:10.1016/j.amjmed.2007.01.024. ISSN 0002-9343.
  7. ↑ Min, Kyung-Whan; Gyorkey, Ferene; Sato, Clifford (1980). “Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis. Pathogenetic role of tumor mucin”. Cancer. 45 (9): 2374–2382. doi:10.1002/1097-0142(19800501)45:9<2374::AID-CNCR2820450923>3.0.CO;2-J. ISSN 0008-543X.
  8. ↑ Dhawan VK (2002). “Infective endocarditis in elderly patients”. Clin Infect Dis. 34 (6): 806–12. doi:10.1086/339045. PMID 11830803.
  9. ↑ Moss R, Munt B (2003). “Injection drug use and right sided endocarditis”. Heart. 89 (5): 577–81. PMC 1767660. PMID 12695478.
  10. ↑ Silverman ME, Upshaw CB (December 2007). “Extracardiac manifestations of infective endocarditis and their historical descriptions”. Am. J. Cardiol. 100 (12): 1802–7. doi:10.1016/j.amjcard.2007.07.034. PMID 18082531.
  11. ↑ Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, Hoen B, Chosidow O, Duval X (May 2014). “Prognostic value of skin manifestations of infective endocarditis”. JAMA Dermatol. 150 (5): 494–500. doi:10.1001/jamadermatol.2013.8727. PMID 24500311.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2] Cafer Zorkun, M.D., Ph.D. [3]